Clinical Trial

Extraperitoneal SINgle-port rObotic-assisted Radical Prostatectomy (RARP) Versus Transperitoneal Multi-port RARP in the Treatment Of Prostate Cancer (SINO-TOP)

Recruiting
View on ClinicalTrials.gov →
Summary
This study is a two-arm, multicenter, randomized controlled clinical trial on whether single-port extraperitoneal VIP RARP is non-inferior to multi-port transperitoneal RARP in terms of functional recovery rate and other key metrics.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2025-06 -> 2028-06 2026-07-24
minor Completion pushed: 2025-12 -> 2028-12 2026-07-24
Trial Details
NCT Number NCT06238713
Lead Sponsor Shanghai Changzheng Hospital
Collaborators: Shanghai Zhongshan Hospital, ShuGuang Hospital, Eastern Hepatobiliary Surgery Hospital, The First Affiliated Hospital of Guangzhou Medical University, Sir Run Run Shaw Hospital, Sichuan Provincial People's Hospital
Conditions Prostate Adenocarcinoma, Localized Prostate Carcinoma
Enrollment 480 participants
Start Date 2024-01-08
Primary Completion 2028-06 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-23